These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 11022947)
21. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly. Houghton AR; Harrison M; Cowley AJ Eur J Heart Fail; 1999 Dec; 1(4):385-93. PubMed ID: 10937952 [TBL] [Abstract][Full Text] [Related]
22. [ELITE II. AT1-blockers not better, but more tolerable than ACE-inhibitors]. Berger D Internist (Berl); 2000 Jan; 41(1):A37. PubMed ID: 10712087 [No Abstract] [Full Text] [Related]
23. Update of ELITE-II, BEST, CHAMP, and IMPRESS clinical trials in heart failure. Witte K; Thackray S; Banerjee T; Clark AL; Cleland JG Eur J Heart Fail; 2000 Mar; 2(1):107-12. PubMed ID: 10742710 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin II receptor antagonists for heart failure. Struthers AD Heart; 1998 Jul; 80(1):5-6. PubMed ID: 9764049 [No Abstract] [Full Text] [Related]
25. EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction. Lynch JJ; Stump GL; Wallace AA; Painter CA; Thomas JM; Kusma SE; Gould RJ; Grossman W J Am Coll Cardiol; 1999 Sep; 34(3):876-84. PubMed ID: 10483973 [TBL] [Abstract][Full Text] [Related]
26. Is losartan superior to captopril in reducing all-cause mortality in elderly patients with symptomatic heart failure? Trojian TH; Jackson EA J Fam Pract; 2000 Aug; 49(8):759-60. PubMed ID: 10947144 [No Abstract] [Full Text] [Related]
27. [Review of randomized trials of angiotensin receptor blockers in the treatment of patients with congestive heart failure]. Rakugi H; Ogihara T Nihon Rinsho; 2001 Oct; 59(10):2051-61. PubMed ID: 11676153 [TBL] [Abstract][Full Text] [Related]
28. [A-II blocker or ACE inhibitor in heart failure? Captopril can't be beat]. Einecke D MMW Fortschr Med; 1999 Nov; 141(47):4-5. PubMed ID: 10912155 [No Abstract] [Full Text] [Related]
29. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. Pitt B; Poole-Wilson PA; Segal R; Martinez FA; Dickstein K; Camm AJ; Konstam MA; Riegger G; Klinger GH; Neaton J; Sharma D; Thiyagarajan B Lancet; 2000 May; 355(9215):1582-7. PubMed ID: 10821361 [TBL] [Abstract][Full Text] [Related]
30. ACE inhibitors still the drug of choice for heart failure--and more. Topol E Lancet; 1999 Nov; 354(9192):1797. PubMed ID: 10577651 [No Abstract] [Full Text] [Related]
31. Blood pressure and renin angiotensin system responses to initiation of treatment with captopril or losartan in heart failure. Squire IB; Robb S; Brennan G; O'Kane KP; Dargie HJ; Reid JL Br J Clin Pharmacol; 1999 Sep; 48(3):464-5. PubMed ID: 10576791 [No Abstract] [Full Text] [Related]
33. Losartan versus captopril in elderly patients with heart failure. Fournier A; Achard JM; Fernandez LA Lancet; 1997 May; 349(9063):1473-4; author reply 1475. PubMed ID: 9164336 [No Abstract] [Full Text] [Related]
34. Are angiotensin II receptor blockers indicated in chronic heart failure? Komajda M Heart; 2002 Jan; 87(1):1-2. PubMed ID: 11751648 [No Abstract] [Full Text] [Related]
35. Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan. Dickstein K; Kjekshus J; Am J Cardiol; 2001 Mar; 87(6):766-71, A7. PubMed ID: 11249900 [TBL] [Abstract][Full Text] [Related]